Skip to main content
Carolyn Mulroney, MD, Oncology, San Diego, CA

CarolynMarieMulroneyMD

Oncology • San Diego, CA

Associate Clinical Professor, Medicine, Blood and Marrow Transplant, UCSD School of Medicine

Join to view full profile

Dr. Mulroney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mulroney's full profile

Already have an account?

  • Office

    200 W Arbor Dr
    San Diego, CA 92103
    Phone+1 858-822-6200
    Fax+1 858-822-6844

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1990 - 1992
  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1989 - 1990
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1986 - 1990
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1986
  • University of Pennsylvania
    University of PennsylvaniaBA, Biochemistry, 1978 - 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1990 - 2025
  • NV State Medical License
    NV State Medical License 2024 - 2025
  • NC State Medical License
    NC State Medical License 1989 - 1990
  • WA State Medical License
    WA State Medical License 1989 - 1990
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

Abstracts/Posters

  • Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone As Salvage Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Sa...
    Carolyn Mulroney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone As Salvage Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Sa...
    Carolyn Mulroney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

Dr. Carolyn Mulroney, Dr. Carolyn Mulroney, MD, Dr. C Mulroney, Dr. Carolyn Marie Mulroney